Exclusão do eculizumabe para tratamento da hemoglobinúria paroxística noturna
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1291817

Rendesivir para tratamento de pacientes com COVID-19 hospitalizados com pneumonia e necessidade de suplementação de oxigênio
https://sites.bvsalud.org/redetsa/brisa/resource/?id=biblioref.referencesource.1291826

FDA Authorizes Software that Can Help Identify Prostate Cancer
http://www.fda.gov/news-events/press-announcements/fda-authorizes-software-can-help-identify-prostate-cancer

Instrument Manager (2021-09-04)
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/76467r-eng.php

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/integradose-compounding-services-llc-issues-voluntary-nationwide-recall-cefazolin-injection-products

FDA Approves First Biosimilar to Treat Macular Degeneration Disease and Other Eye Conditions
http://www.fda.gov/news-events/press-announcements/fda-approves-first-biosimilar-treat-macular-degeneration-disease-and-other-eye-conditions

FDA In Brief: FDA Posts an Initial Batch of Four Deemed Final Administrative Orders for Over-the-Counter Drugs
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-posts-initial-batch-four-deemed-final-administrative-orders-over-counter-drugs

Coronavirus (COVID-19) Update: September 17, 2021
http://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-september-17-2021

Federal Court Enters Consent Decree Against Florida Compounder, Prohibiting Manufacture and Distribution of Drugs Due to Insanitary Conditions
http://www.fda.gov/news-events/press-announcements/federal-court-enters-consent-decree-against-florida-compounder-prohibiting-manufacture-and

FDA In Brief: FDA Hosts Third Summit Focused on Reducing the Availability of Opioids Online
http://www.fda.gov/news-events/press-announcements/fda-brief-fda-hosts-third-summit-focused-reducing-availability-opioids-online